Safety in Aflibercept versus Ranibizumab – Corrected Proof

Aflibercept seems to have equivalent effectiveness to ranibizumab, even though it requires less frequent injections. Although the effectiveness of vascular endothelial growth factor (VEGF) inhibitors for age-related macular degeneration (AMD) is unquestionable, there has been some concern for the systemic vascular safety, especially relating to cerebrovascular risk.

Full Story →